Manufacturer record
Park Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by Park Pharmaceuticals (Haryana) were declared Not of Standard Quality between May 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: YMC-2534, Pantoprazole for Injection IP (exp Aug 2027). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per I.P. Addendum 2024 in respect to the Test of Sterility. Listed in the September 2026 alert.
Records by type
15 records linked to Park Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole for Injection IP | Batch YMC-2534Mfg Sep 2025 · Exp Aug 2027 | The sample does not conform to claim as per I.P. Addendum 2024 in respect to the Test of SterilitySterility | RDTL, GuwahatiCDSCO lab | Sep 2026 |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup IP | Batch KKP-006Mfg Feb 2025 · Exp Jan 2027 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Amoxycillin & Potasium Clavulanate Tablets I.P. 625 mg | Batch BRE-172Mfg Jul 2025 · Exp Dec 2026 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, AssamState lab | Mar 2026 |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tab | Batch CHTC4419Mfg Mar 2025 · Exp Feb 2027 | 1) The sample declared as Not of Standard Quality in assay of Potassium Clavunalate e.q. to Clavulanic acid. 2) The sample does not conform to claim.Assay | SDTL, Kolkata, WBState lab | Feb 2026 |
| Ofloxacin & Ornidazole Tablets IP | Batch OBT-2972Mfg Apr 2024 · Exp Mar 2026 | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab | Jan 2026 |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | Batch CHO-50003Mfg Jan 2025 · Exp Dec 2026 | Assay for Cefixime (as Anhydrous) & Azithromycin (as Anhydrous) onlyAssay | RDTL, Hubli, KarnatakaState lab | Jan 2026 |
| Cefidxime, Azithromycin & Lactic Acid Baciullus Tablets | Batch MM-241491Mfg Feb 2025 · Exp Jan 2027 | Assay for Cefixime (as anhydrous) & Azithromycin (as Anhydrous)Assay | KarnatakaState lab | Aug 2025 |
| Amoxycillin & Potasium Clavulanate Tablets I.P. (IPHA CLAV-375) | Batch NCP-151Mfg Jan 2024 · Exp Jun 2025 | Assay of Clavulanic AcidAssay | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| CLAVPARK -LB 625mg (Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tab) | Batch CHTJ426 0Mfg Oct 2024 · Exp Sep 2026 | Does not confirm to claimOther | SDTL KolkataState lab | Jan 2025 |
| Odeflox ? OZ (Ofloxacin & Ornidazole Tablets IP) | Batch PR-202205Mfg Feb 2022 · Exp Jan 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2023 |
| Azithromycin Tablets IP (BARLOCIN-250) | Batch BL-12913Mfg Dec 2021 · Exp Nov 2023 | Assay & DissolutionAssay | RDTL GuwahatiState lab | Feb 2023 |
| Amoxycillin & Potassium Clavulanate Tablets IP CLAVPARK 625 | Batch CH042014Mfg Apr 2022 · Exp Mar 2024 | Assay of Clavulanic Acid and Dissolution of Amoxycillin and Clavulanic AcidAssay | RDTL GuwahatiState lab | Feb 2023 |
| Secef - CV (Cefixime & Potassium Clavulanate Tablets) | Batch TPP-014Mfg Oct 2021 · Exp Mar 2023 | Assay of Cefixime & Potassium ClavulanateAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Moxiford Eye Drops (Moxifloxacin Eye Drops I.P.) | Batch LHL-2692Mfg Aug 2018 · Exp Jul 2020 | Description & AssayAssay | CDL KolkataCDSCO lab | Oct 2019 |
| Ofloxacin Tablets I.P. (DRFLOX-200) | Batch DRB-009Mfg Jul 2017 · Exp Jun 2019 | DissolutionDissolution | RDTL GuwahatiState lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.